Leaderboard

En | De
Sie sind hier: Gastroenterologie » Leber » Leberzirrhose 15. Juli 2026
Suchen
medline.ch
Leberzirrhose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1946  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 38905  
   
Transcriptomic Identification of Diagnostic Biomarkers for Alcohol-Associated Liver Cirrhosis: Integration of Population-Level Epidemiology with Multi-Cohort Transcriptomic Analysis.
Int J Mol Sci
Wang H, Ding W, Zhang L, Xu M, Sui J.
PMID: 42450082 [PubMed - in process]


Evaluation of Kidney Function in Cirrhosis: Methods and Pitfalls.
Diagnostics (Basel)
Gil-Lopez F, Parikh N, Mai M, Chirila R, Wadei HM.
PMID: 42449869 [PubMed]


Delayed Mortality After Successful Hemostasis in Cirrhotic Upper Gastrointestinal Bleeding: A Prospective Observational Study.
Clin Res Hepatol Gastroenterol
Badwei N, El-Folly RF, Abdu Hemdan HA, Mohamed Wassif GO, Yousry Kabiel WA, Marzouk Biomy MA.
PMID: 42448148 [PubMed - as supplied by publisher]


Revisiting two-stage models of chemically-induced cirrhosis-associated hepatocarcinogenesis in rodents: methodological and histopathological approaches.
J Mol Histol
da Fonseca ARB, de Magalhães Junior PFC, Barbisan LF.
PMID: 42446627 [PubMed - indexed for MEDLINE]


Best Practice: Implementation of Liver US Shear-Wave Elastography in Clinical Practice.
Radiology
Parameswaran M, Baikpour M, Hunt DT, Orlowski M, Samir AE, Pierce TT.
PMID: 42446359 [PubMed - indexed for MEDLINE]


Rifaximin Plus Probiotics Reshape Gut Microbiota, Serum Propionate, and Mucosal Immunity in Cirrhosis-Related Hepatic Encephalopathy Microbiota-Immune Remodeling in HE.
Can J Gastroenterol Hepatol
Wang Y, Zhu H, Wang S, Hu D, Xu M, Lee L, Lee D.
PMID: 42444028 [PubMed - indexed for MEDLINE]


Effectiveness of Risk-Stratified Evidence-Based Nursing at Different Time Points in Cirrhosis with Upper Gastrointestinal Bleeding.
J Vis Exp
Zhang L, Gu Y, Xi S, Yan L, Liu X, Yang S, Zhang X.
PMID: 42441707 [PubMed - indexed for MEDLINE]


[Hepatic Overlap Syndrome: Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Case Review].
Rev Med Chil
Aronsohn F, Poniachik J.
PMID: 42441677 [PubMed - indexed for MEDLINE]


Machine learning modeling to predict HCC locations in cirrhotic patients undergoing MRI - a proof-of-concept study.
Abdom Radiol (NY)
Gaddum O, Zeevi T, Dai W, Lin M, Thomas S, Tefera J, Sobirey R, Matuschewski NJ, Gross M, Abosabie SA, Abosabie SAS, Gebauer B, Savic LJ, Madoff DC, Duncan JS, Chapiro J.
PMID: 42440113 [PubMed - as supplied by publisher]


Microwave ablation of malignant liver lesions: Does the presence of cirrhosis affect the diameter of the ablation zones? A retrospective comparative study from a single institution.
Br J Radiol
Shaygi B Dr, Burger R Dr, Reed W, Ashraf N Dr, Weston-Petrides G Miss, Puttick T Dr, Hamed A Professor, Luigi R Dr, Peddu P Dr.
PMID: 42439537 [PubMed - as supplied by publisher]


Impact of the Number of Remaining Natural Teeth on Decompensation and Survival in Patients With Compensated Liver Cirrhosis.
Hepatol Res
Nakatani T, Namisaki T, Takaya H, Inoue T, Shibamoto A, Iwai S, Oyama M, Hanatahi J, Nishimura N, Tsuji Y, Fujinaga Y, Sato S, Nishimura N, Kitagawa K, Kaji K, Mitoro A, Akahane T, Yoshiji H.
PMID: 42438897 [PubMed - as supplied by publisher]


Response to "Comment on 'Using Serum Creatinine-To-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis'".
Hepatol Res
Shibamoto A, Namisaki T, Takami M, Masuda H, Inoue T, Iwai S, Asada S, Tsuji Y, Fujinaga Y, Sato S, Nishimura N, Kitagawa K, Takaya H, Kaji K, Mitoro A, Asada K, Yoshiji H.
PMID: 42438212 [PubMed - as supplied by publisher]


Drug Development for MASH-Related Compensated Cirrhosis: Past, Present and Future.
Liver Int
Zeng RQ, Shao YX, Lin RT, Shen XT, Sun QM, Xin X, Liu P, Fan JG, Hu YY, Feng Q.
PMID: 42438128 [PubMed - indexed for MEDLINE]


The Use of FGF21 Analogues in MASH and MASH Cirrhosis - Metabolic Master Regulators or Liver-Specific Mechanisms? (☆).
JHEP Rep
Holleboom AG, Schattenberg JM.
PMID: 42435974 [PubMed - as supplied by publisher]


Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.
United European Gastroenterol J
Pompili E, Zaccherini G, Nardelli S, Piano S, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Simone L, Svegliati-Baroni G, Fagiuoli S, Marra F, Cozzolongo R, Iannone G, Biselli M, Riggio O, Angeli P, Bernardi M, Baldassarre M, Caraceni P, ANSWER Study Investigators.
PMID: 42435328 [PubMed - indexed for MEDLINE]


Comparative Assessment of Salivary Neutrophil Gelatinase-Associated Lipocalin Levels (NGAL) Among Subjects With Periodontitis, Liver Cirrhosis, and Healthy Individuals: A Cross-Sectional Study.
Cureus
Dongare SS, Zope SA, Suragimath G, Varma S, Kale AV.
PMID: 42434656 [PubMed]


Association of fat-related metabolic indices with MASLD and liver fibrosis: a cross-sectional analysis of NHANES 2017-2020.
Medicine (Baltimore)
Shen N, Wei Q, Zhao J, Cai J.
PMID: 42432919 [PubMed - indexed for MEDLINE]


Albumin-to-creatinine ratio as non-invasive marker for prediction of non- bleeding esophageal varices. a cross-sectional observational study.
BMC Gastroenterol
Mousa N, Elmetwalli A, Abdelsalam M, Wahba M, El-Wakeel N, Mansour M, Selim M, Diasty M, Abdelkader E, El-Assmy A, Abdelaziz M, El-Assmy A, Alhawarey A.
PMID: 42432532 [PubMed - indexed for MEDLINE]


Renal Resistive Index as a Novel Predictor of Contrast-Induced Acute Kidney Injury in Cirrhosis.
Cureus
Jacob Skariah J, Solanki R, John J, N V A, T S P, George A, Varghese J, Devadas K.
PMID: 42428176 [PubMed]


Letter on 'Network Meta-Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution'. Authors' Reply.
Aliment Pharmacol Ther
Souza M, Huang DQ, Loomba R.
PMID: 42426941 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 38905    Seite 1 von 1946  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1